Heart FailurePhase 2PROMICNCT02436161
Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients With Heart Failure (PROMIC)
A Phase 2 study testing Care management program "PROMIC" in people with Heart Failure, run by Basque Health Service.
Trial summary
OBJECTIVE: To evaluate the effectiveness of a multidisciplinary care management collaborative program for high-risk patients with heart failure (HF) who are admitted at hospital, based on the 6 components of the Chronic Care Model "PROMIC", in terms of reduction of a Combined event rate (readmissions / cardiac events… Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Heart Failure
- What is being tested?
- Care management program "PROMIC"
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 250 participants
- Where
- No sites listed yet
- Study dates
- May 2011to Apr 2015
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients admitted at hospital because of HF in II to IV NYHA stage
Who cannot join
- life expectancy below 3 months
- discharge to nursing home
- Severe cognitive impairment
About this study
Official title: Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients Who Are Admitted at Hospital Because of Heart Failure (PROMIC)
OBJECTIVE: To evaluate the effectiveness of a multidisciplinary care management collaborative program for high-risk patients with heart failure (HF) who are admitted at hospital, based on the 6 components of the Chronic Care Model "PROMIC", in terms of reduction of a Combined event rate (readmissions / cardiac events / death / emergency department visits) and other variables, the feasibility of the program, the improvement on quality of life related to health and functional capacity of the PROMIC patients compared with control patients in usual care.
DESIGN: A quasi-experimental, prospective one year follow-up study. SETTING AND SUBJECTS: Primary Health care Centres of Interior County in Bizkaia and of Araba County in Araba, Galdakao Hospital, Santa Marina Hospital and University hospital os Araba in the Basque Country. Will be captured as a minimum intervention group of 125 patients admitted for HF in New York Heart Association (NYHA) functional status II-III-IV from previous mentioned hospitals. Another 125 patients from different primary health care centers, will be the control group.
Read more
INTERVENTION: The intervention to be applied will be PROMIC, control patients will receive usual care MEASUREMENTS: The mean outcome measure will be the time free of events from the time of inclusion to the first event (readmission / cardiac events / death / emergency visits). Secondary endpoints will be the quality of life related to health (MLFHQ and SF-12), functional capacity (6-Minute Walk Test), structural changes in cardiac structure (natriuretic peptide levels), adherence to drug treatment (Morinsky-Green), the cost of the program, the usefulness and acceptability of PROMIC by professionals and patients. Predictor variables also will be collected such as sex, age, education level, co-morbidity, social risk level, dependency etc.
STATISTICAL ANALYSIS: Analysis was performed by intention to treat. Survival curves will done. A model of Cox proportional hazards will be built.
Read the detailed description
INTRODUCTION In light of the increased prevalence of chronic diseases and comorbidities as a result of the increased life expectancy of the population, the need to develop care models that adequately respond to the healthcare and sociodemographic needs of the populatión in the actual context in which they are applied has been proposed. Patients with chronic and/or multiple diseases present the greatest health care needs and tend to experience the imbalances in the system with the greatest intensity. Investigators have concentrated the research on patients admitted because of HF due to the high prevalence and complexity of this disease and the fact that such patients present multiple chronic conditions. These patients are normally elderly and present high degrees of comorbidity and poly-medication, poor treatment adherence and difficulties in selfcare. The majority of patients admitted with HF are in level 3 of the Kaiser pyramid together with other patients with complex health care needs.
There is some evidence that a higher degree of multidisciplinarity results in better team coordinatión and training and more effective care for complex high-risk patients, of which HF patients are a good example.
PROMIC is an organisational care management innovation that provides a comprehensive and integrated approach to patients with a high degree of complexity, in this case, patients admitted with HF.
It promotes the integratión of care in different healthcare settings with the change of the nurses role and self-care training in patients. As such, PROMIC helps to ensure the continuity of patients care in their own environment.
The aim of the innovative care model that PROMIC is intended to provide in high-risk HF patients is to improve health outcomes and to modify the current care model for chronic diseases, thereby serving as the foundation for future interventions targetting other chronic patients with multiple comorbidities and complex health care needs. Indeed, precisely due to the presence of comorbidities in this type of patient, investigators consider coordination with consultants from other specialities to be essential. As HF patients present marked comorbidity, investigators expect that the experience acquired during this project will help them to design interventions that can be broadened to cover all complex chronic patients likely to benefit from a care management programs.
OBJECTIVES
- To evaluate the effectiveness of a multidisciplinary care management collaborative program for high-risk patients with HF who are admitted at hospital, based on the 6 components of the Chronic Care Model "PROMIC", in terms of reduced Combined event rate (readmissions / cardiac events / death / emergency department visits) and other variables, the feasibility of the program, the improvement on quality of life related to health and functional capacity of the PROMIC patients compared with control patients in usual care.
- To understand the opinion of the professionals involved in the process using discussion and consensus methods in order to design the most effective and comprehensive clinical and organisational intervention.
The goal of this project is to establish a sustainable care model for patients admitted with HF that improves their health outcomes. The understanding gained during implementation of this model will lead to further research involving the care of other types of complex chronic patients.
METHODOLOGY DESIGN: A quasi-experimental, prospective one year follow-up study. SETTING AND SUBJECTS: Primary Health care Centres of Interior County in Bizkaia and of Araba County in Araba, Galdakao Hospital, Santa Marina Hospital and University hospital os Araba in the Basque Country. Will be captured as a minimum intervention group of 125 patients admitted for HF in NYHA functional status II-III-IV from previous mentioned hospitals. Another 125 patients from different primary health care centers will be the control group.
INTERVENTION: The intervention to be applied will be PROMIC, control patients will receive usual care.
PROMIC is an organizational innovation comprising a complex intervention containing components supported by scientific evidence from both a content based on clinical practice guidelines, (CPGs) as well as regarding its implementation, which is based on the Chronic Care Model (CCM), developed by Ed Wagner at the McColl Institute (Seattle, USA) in the 1990s. As this is a complex intervention, investigators have selected the theoretical and methodological framework for the design and evaluation of complex interventions in a clinical setting developed by the healthcare and public health services working group of the United Kingdom Medical Research Council (MRC), which comprises four phases.
In phase 0 investigators have undertaken a strategic needs research and evaluation process and a comprehensive literature search regarding the management of HF patients and complex chronic comorbid patients in order to identify and select areas for optimization. Phase 1 comprised the design of the intervention program in collaboratión with professionals from the fields of primary care, hospital and social care, as well as primary researchers and managers, and the piloting of the intervention with a small number of patients and taking into account the actual context in the Basque country public health system where Primary care is very well developed and effective and with a high quality hospital care. The piloting of the intervention was deployed in 15 polymedicated (mean of 11 drugs) patients admitted with HF and multiple comorbidities (mean of six chronic diseases) to confirm its feasibility. This pilot study concluded with positive results and led to the implementation of a quasi-experimental phase 2 trial.
Intervention (PROMIC) was performed in the framework of each of the six components of the CCM.
- Healthcare organisation. Investigators held 18 joint working sessions involving all components of the multidisciplinary team to establish the content of the clinical care and organisational interventions.
- Delivery system design. A care management model describing the circuits and communications between healthcare and non-healthcare professionals was defined in these joint sessions.
- Use of clinical information systems. Investigators use an electronic case history shared by all professionals involved in patient care, which acts as a care record and action reminder.
- Decision-making support. Investigators have standardised the information contained in the discharge planning report and the communications between professionals in the return home and protocolized the pharmacological treatments indicated in the guidelines. The individual problems presented by each patient are managed with a comprehensive and personalized intervention. Investigators have designed a theoretical/practical training plan for all study participants 27 hours for physicians and 42 hours for nurses, which has been complemented with a course on electrocardiography, basic recommendations for cardiology and drug titration for nursing staff.
- Education about self-care and empowerment of patients and their families. Creation of a new nursing role aimed at coaching and educating patients and their families and evaluating their level of understanding and self-care. Investigators have prepared educational support material for personalized self-care aimed at patients and their carers.
- Integration of community resources. Investigators have established meetings and contacts with social workers and community pharmacists.
MEASUREMENTS: The mean outcome measure will be the time free of events from the time of inclusion to the first event (readmission / cardiac events / death / emergency visits). Secondary endpoints will be the quality of life related to health (MLFHQ and SF-12), functional capacity (6-Minute Walk Test), structural changes in cardiac structure (brain natriuretic peptide BNP), adherence to drug treatment (Morinsky- Green questionaire), the cost of the program based in the adjusted clinical group (ACG) , the usefulness and acceptability of PROMIC by professionals and patients. Predictor variables also will be collected such as sex, age, education level, co-morbidity, social risk level and dependency
baseline 6ºmonth 12º month
MLFHQ X X X
SF-12 X X X
6-Minute Walk Test X X X
BNP levels X X X
Morinsky-Green X X X
HFSBS X X X
Charlson Index X X X
Memory impairment Screen (MIS)X X X
HAD (<70years) X X X
Yesavage(>70years) X X X
Duke X X X
Lawton y Brody X X X
Barthel X X X
Zarit X X X
Social evaluation scale X X X
Professional focus group X
Cost X
Perception of integrated care D'Amour X
STATISTICAL ANALYSIS: Analysis was performed by intention to treat. Survival curves will done. A model of Cox proportional hazards will be built.
- Conditions
- Heart Failure
- Being tested
- Care management program "PROMIC"
- Keywords
- Heart Failure, Comorbidity, Patient Care Management, Primary Health Care, Delivery of Health Care, Integrated
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Care management program "PROMIC"Behavioural
intensive coaching intervention to optimize care and prevent readmissions, using educational selfcare and worsening symptoms recognition by patients and carers
| Study group | Role | What they receive |
|---|---|---|
| Care management program "PROMIC" | Experimental | care management program provided by a multidisciplinary team that optimizes care with the main role of nurses acting as coaches of patients and carers, within the primary care teams Receives: Behavioral: Care management program "PROMIC" |
| Usual care | No intervention | Patients in the control group belongs to different Primary health care centres from the intervention group and are treated as usual by their Primary Care team and by cardiologists different from the intervention group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hospital readmissions because of HF
Measured: one year
Secondary outcomes (4)
Quality of life measured by Minnesota Questionaire and SF12 Questionaire
Measured: one year
self management knowledge measured by the Heart Failure Self Behaviour Scale
Measured: one year
Cost of the program
Measured: one year
professional perception of integrated care measured by the D'Amour Questionaire
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2015 (estimated)
- Study startMay 2011
- Primary completionMay 2013
- Study completionApr 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 250 participants (actual)
Sponsor and investigators
- Lead sponsor
- Basque Health Service
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Cristina Domingo, Basque Health Service
- Investigators
- Cristina Domingo, MD, FAM PHY, Principal investigator, Basque Health Service
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02436161
- Sponsor's protocol ID
- BG2010111182
- Acronym
- PROMIC
- Status last verified
- May 2015
- First submitted
- 26 Apr 2015
- Last updated
- 6 May 2015
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients Who Are Admitted at Hospital Because of Heart Failure (PROMIC)
- ClinicalTrials.gov ID
- NCT02436161
- Acronym / sponsor ID
- PROMIC / BG2010111182
- Conditions
- Heart Failure
- Keywords
- Heart Failure, Comorbidity, Patient Care Management, Primary Health Care, Delivery of Health Care, Integrated
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 250 participants (actual)
- Lead sponsor
- Basque Health ServiceOther government
- Study start
- May 2011
- Primary completion
- May 2013 (actual)
- Study completion
- Apr 2015 (actual)
- First posted
- 6 May 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
OBJECTIVE: To evaluate the effectiveness of a multidisciplinary care management collaborative program for high-risk patients with heart failure (HF) who are admitted at hospital, based on the 6 components of the Chronic Care Model "PROMIC", in terms of reduction of a Combined event rate (readmissions / cardiac events / death / emergency department visits) and other variables, the feasibility of the program, the improvement on quality of life related to health and functional capacity of the PROMIC patients compared with control patients in usual care.
DESIGN: A quasi-experimental, prospective one year follow-up study. SETTING AND SUBJECTS: Primary Health care Centres of Interior County in Bizkaia and of Araba County in Araba, Galdakao Hospital, Santa Marina Hospital and University hospital os Araba in the Basque Country. Will be captured as a minimum intervention group of 125 patients admitted for HF in New York Heart Association (NYHA) functional status II-III-IV from previous mentioned hospitals. Another 125 patients from different primary health care centers, will be the control group.
INTERVENTION: The intervention to be applied will be PROMIC, control patients will receive usual care MEASUREMENTS: The mean outcome measure will be the time free of events from the time of inclusion to the first event (readmission / cardiac events / death / emergency visits). Secondary endpoints will be the quality of life related to health (MLFHQ and SF-12), functional capacity (6-Minute Walk Test), structural changes in cardiac structure (natriuretic peptide levels), adherence to drug treatment (Morinsky-Green), the cost of the program, the usefulness and acceptability of PROMIC by professionals and patients. Predictor variables also will be collected such as sex, age, education level, co-morbidity, social risk level, dependency etc.
STATISTICAL ANALYSIS: Analysis was performed by intention to treat. Survival curves will done. A model of Cox proportional hazards will be built.
Detailed description
INTRODUCTION In light of the increased prevalence of chronic diseases and comorbidities as a result of the increased life expectancy of the population, the need to develop care models that adequately respond to the healthcare and sociodemographic needs of the populatión in the actual context in which they are applied has been proposed. Patients with chronic and/or multiple diseases present the greatest health care needs and tend to experience the imbalances in the system with the greatest intensity. Investigators have concentrated the research on patients admitted because of HF due to the high prevalence and complexity of this disease and the fact that such patients present multiple chronic conditions. These patients are normally elderly and present high degrees of comorbidity and poly-medication, poor treatment adherence and difficulties in selfcare. The majority of patients admitted with HF are in level 3 of the Kaiser pyramid together with other patients with complex health care needs.
There is some evidence that a higher degree of multidisciplinarity results in better team coordinatión and training and more effective care for complex high-risk patients, of which HF patients are a good example.
PROMIC is an organisational care management innovation that provides a comprehensive and integrated approach to patients with a high degree of complexity, in this case, patients admitted with HF.
It promotes the integratión of care in different healthcare settings with the change of the nurses role and self-care training in patients. As such, PROMIC helps to ensure the continuity of patients care in their own environment.
The aim of the innovative care model that PROMIC is intended to provide in high-risk HF patients is to improve health outcomes and to modify the current care model for chronic diseases, thereby serving as the foundation for future interventions targetting other chronic patients with multiple comorbidities and complex health care needs. Indeed, precisely due to the presence of comorbidities in this type of patient, investigators consider coordination with consultants from other specialities to be essential. As HF patients present marked comorbidity, investigators expect that the experience acquired during this project will help them to design interventions that can be broadened to cover all complex chronic patients likely to benefit from a care management programs.
OBJECTIVES
- To evaluate the effectiveness of a multidisciplinary care management collaborative program for high-risk patients with HF who are admitted at hospital, based on the 6 components of the Chronic Care Model "PROMIC", in terms of reduced Combined event rate (readmissions / cardiac events / death / emergency department visits) and other variables, the feasibility of the program, the improvement on quality of life related to health and functional capacity of the PROMIC patients compared with control patients in usual care.
- To understand the opinion of the professionals involved in the process using discussion and consensus methods in order to design the most effective and comprehensive clinical and organisational intervention.
The goal of this project is to establish a sustainable care model for patients admitted with HF that improves their health outcomes. The understanding gained during implementation of this model will lead to further research involving the care of other types of complex chronic patients.
METHODOLOGY DESIGN: A quasi-experimental, prospective one year follow-up study. SETTING AND SUBJECTS: Primary Health care Centres of Interior County in Bizkaia and of Araba County in Araba, Galdakao Hospital, Santa Marina Hospital and University hospital os Araba in the Basque Country. Will be captured as a minimum intervention group of 125 patients admitted for HF in NYHA functional status II-III-IV from previous mentioned hospitals. Another 125 patients from different primary health care centers will be the control group.
INTERVENTION: The intervention to be applied will be PROMIC, control patients will receive usual care.
PROMIC is an organizational innovation comprising a complex intervention containing components supported by scientific evidence from both a content based on clinical practice guidelines, (CPGs) as well as regarding its implementation, which is based on the Chronic Care Model (CCM), developed by Ed Wagner at the McColl Institute (Seattle, USA) in the 1990s. As this is a complex intervention, investigators have selected the theoretical and methodological framework for the design and evaluation of complex interventions in a clinical setting developed by the healthcare and public health services working group of the United Kingdom Medical Research Council (MRC), which comprises four phases.
In phase 0 investigators have undertaken a strategic needs research and evaluation process and a comprehensive literature search regarding the management of HF patients and complex chronic comorbid patients in order to identify and select areas for optimization. Phase 1 comprised the design of the intervention program in collaboratión with professionals from the fields of primary care, hospital and social care, as well as primary researchers and managers, and the piloting of the intervention with a small number of patients and taking into account the actual context in the Basque country public health system where Primary care is very well developed and effective and with a high quality hospital care. The piloting of the intervention was deployed in 15 polymedicated (mean of 11 drugs) patients admitted with HF and multiple comorbidities (mean of six chronic diseases) to confirm its feasibility. This pilot study concluded with positive results and led to the implementation of a quasi-experimental phase 2 trial.
Intervention (PROMIC) was performed in the framework of each of the six components of the CCM.
- Healthcare organisation. Investigators held 18 joint working sessions involving all components of the multidisciplinary team to establish the content of the clinical care and organisational interventions.
- Delivery system design. A care management model describing the circuits and communications between healthcare and non-healthcare professionals was defined in these joint sessions.
- Use of clinical information systems. Investigators use an electronic case history shared by all professionals involved in patient care, which acts as a care record and action reminder.
- Decision-making support. Investigators have standardised the information contained in the discharge planning report and the communications between professionals in the return home and protocolized the pharmacological treatments indicated in the guidelines. The individual problems presented by each patient are managed with a comprehensive and personalized intervention. Investigators have designed a theoretical/practical training plan for all study participants 27 hours for physicians and 42 hours for nurses, which has been complemented with a course on electrocardiography, basic recommendations for cardiology and drug titration for nursing staff.
- Education about self-care and empowerment of patients and their families. Creation of a new nursing role aimed at coaching and educating patients and their families and evaluating their level of understanding and self-care. Investigators have prepared educational support material for personalized self-care aimed at patients and their carers.
- Integration of community resources. Investigators have established meetings and contacts with social workers and community pharmacists.
MEASUREMENTS: The mean outcome measure will be the time free of events from the time of inclusion to the first event (readmission / cardiac events / death / emergency visits). Secondary endpoints will be the quality of life related to health (MLFHQ and SF-12), functional capacity (6-Minute Walk Test), structural changes in cardiac structure (brain natriuretic peptide BNP), adherence to drug treatment (Morinsky- Green questionaire), the cost of the program based in the adjusted clinical group (ACG) , the usefulness and acceptability of PROMIC by professionals and patients. Predictor variables also will be collected such as sex, age, education level, co-morbidity, social risk level and dependency
baseline 6ºmonth 12º month
MLFHQ X X X
SF-12 X X X
6-Minute Walk Test X X X
BNP levels X X X
Morinsky-Green X X X
HFSBS X X X
Charlson Index X X X
Memory impairment Screen (MIS)X X X
HAD (<70years) X X X
Yesavage(>70years) X X X
Duke X X X
Lawton y Brody X X X
Barthel X X X
Zarit X X X
Social evaluation scale X X X
Professional focus group X
Cost X
Perception of integrated care D'Amour X
STATISTICAL ANALYSIS: Analysis was performed by intention to treat. Survival curves will done. A model of Cox proportional hazards will be built.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Care management program "PROMIC" | Experimental | Behavioral: Care management program "PROMIC"care management program provided by a multidisciplinary team that optimizes care with the main role of nurses acting as coaches of patients and carers, within the primary care teams |
| Usual care | No intervention | –Patients in the control group belongs to different Primary health care centres from the intervention group and are treated as usual by their Primary Care team and by cardiologists different from the intervention group |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients admitted at hospital because of HF in II to IV NYHA stage
Key exclusion criteria (3 listed)
- life expectancy below 3 months
- discharge to nursing home
- Severe cognitive impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Care management program "PROMIC"intensive coaching intervention to optimize care and prevent readmissions, using educational selfcare and worsening symptoms recognition by patients and carers | Behavioural | Care management program "PROMIC" |
Primary outcome
Hospital readmissions because of HF
Time frame: one year
4 secondary outcomes
Quality of life measured by Minnesota Questionaire and SF12 Questionaire
Time frame: one year
self management knowledge measured by the Heart Failure Self Behaviour Scale
Time frame: one year
Cost of the program
Time frame: one year
professional perception of integrated care measured by the D'Amour Questionaire
Time frame: one year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2015.
- phase 0 and 1 of the PROMIC care management programLink provided by the sponsor.
Related trials for Heart Failure
RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Recruiting
Evaluation of the Effects of Sauna Therapy on Congestion and Loop Diuretic Use in Patients With Heart Failure With Reduced or Moderately Reduced Ejection Fraction
Heart Failure
Recruiting
PrEcision Pacing in HFpEF: the PEP-HFpEF Trial
Heart Failure and Preserved Ejection Fraction, Heart Failure New York Heart Association Class III
Enrolling by invitation
EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Heart Failure, Transplant; Failure, Heart
Enrolling by invitationObservational study
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Cristina Domingo, MD, FAM PHY principal investigator
Basque Health Service
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Care management program "PROMIC" in people with Heart Failure, run by Basque Health Service.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hospital readmissions because of HF (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2015.